Your browser doesn't support javascript.
loading
Screening for Rare Coding Variants That Associate With the QTc Interval in Iceland.
Sveinbjornsson, Gardar; Benediktsdottir, Bara D; Sigfusson, Gunnlaugur; Norland, Kristjan; Davidsson, Olafur B; Thorolfsdottir, Rosa B; Tragante, Vinicius; Arnadottir, Gudny A; Jensson, Brynjar O; Katrinardottir, Hildigunnur; Fridriksdottir, Run; Gudmundsdottir, Hallbera; Aegisdottir, Hildur M; Fridriksson, Brynjar; Thorgeirsson, Gudmundur; Magnusson, Vidar; Oddsson, Asmundur; Sulem, Patrick; Gudbjartsson, Daniel F; Holm, Hilma; Arnar, David O; Stefansson, Kari.
Afiliación
  • Sveinbjornsson G; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Benediktsdottir BD; Internal Medicine, Landspitali-The National University Hospital of Iceland Reykjavik Iceland.
  • Sigfusson G; Children's Medical Center Landspítali-The National University Hospital of Iceland Reykjavík Iceland.
  • Norland K; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Davidsson OB; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Thorolfsdottir RB; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Tragante V; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Arnadottir GA; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Jensson BO; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Katrinardottir H; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Fridriksdottir R; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Gudmundsdottir H; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Aegisdottir HM; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Fridriksson B; The Capital District Fire and Rescue Service Reykjavik Iceland.
  • Thorgeirsson G; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Magnusson V; The Capital District Fire and Rescue Service Reykjavik Iceland.
  • Oddsson A; Department of Anesthesia, Landspitali The National University Hospital of Iceland Reykjavik Iceland.
  • Sulem P; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Gudbjartsson DF; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Holm H; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
  • Arnar DO; Faculty of Electrical and Computer Engineering University of Iceland Reykjavik Iceland.
  • Stefansson K; deCODE Genetics/Amgen, Inc. Reykjavik Iceland.
J Am Heart Assoc ; 12(14): e029845, 2023 07 18.
Article en En | MEDLINE | ID: mdl-37449562
ABSTRACT
Background Long-QT syndrome (LQTS) is a cardiac repolarization abnormality that can lead to sudden cardiac death. The most common causes are rare coding variants in the genes KCNQ1, KCNH2, and SCN5A. The data on LQTS epidemiology are limited, and information on expressivity and penetrance of pathogenic variants is sparse. Methods and Results We screened for rare coding variants associated with the corrected QT (QTc) interval in Iceland. We explored the frequency of the identified variants, their penetrance, and their association with severe events. Twelve variants were associated with the QTc interval. Five in KCNQ1, 3 in KCNH2, 2 in cardiomyopathy genes MYBPC3 and PKP2, and 2 in genes where coding variants have not been associated with the QTc interval, ISOC1 and MYOM2. The combined carrier frequency of the 8 variants in the previously known LQTS genes was 530 per 100 000 individuals (1190). p.Tyr315Cys and p.Leu273Phe in KCNQ1 were associated with having a mean QTc interval longer than 500 ms (P=4.2×10-7; odds ratio [OR], 38.6; P=8.4×10-10, OR, 26.5; respectively), and p.Leu273Phe was associated with sudden cardiac death (P=0.0034; OR, 2.99). p.Val215Met in KCNQ1 was carried by 1 in 280 Icelanders, had a smaller effect on the QTc interval (P=1.8×10-44; effect, 22.8 ms), and did not associate with severe clinical events. Conclusions The carrier frequency of associating variants in LQTS genes was higher than previous estimates of the prevalence of LQTS. The variants have variable effects on the QTc interval, and carriers of p.Tyr315Cys and p.Leu273Phe have a more severe disease than carriers of p.Val215Met. These data could lead to improved identification, risk stratification, and a more precise clinical approach to those with QTc prolongation.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Canal de Potasio KCNQ1 Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Canal de Potasio KCNQ1 Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article